Biotechnology
Unitedstates
Therapeutics
Development
Stock
M&A Advisory
Lazard
Full Credential Description
OXiGENE. United States. Announced Date 15/12/2005. Closed Date 15/12/2005. Deal value: $27m. Common stock. Industry: OXiGENE is a biotechnology company focused on developing therapeutics for cancer treatment.